ERBB2 and breast neoplasm: BRCA1-linked breast tumours typically exhibit triple negative expression (ER-/PR-/Her2-) [12], express basal cytokeratins 5 and 6, and EGFR [40-42] and show similar histopathological features to basal-like/triple negative breast cancers [42].